Andera Partners Announces the Appointment of Stefan Keitel as Senior Advisor for the DACH Region
The move will increase the firm's presence in Germany, Austrian, and Switzerland.
Accelerating its ambitions in the German, Austrian and Swiss (DACH) region, Andera Partners announced the appointment of Stefan Keitel as senior advisor. Mr. Keitel joins Andera Partners, a leading European private equity firm, with more than $4.79 billion of assets under management and six investment strategies, to support the firm strategically and in investor relationship throughout the DACH region.
Andera Life Sciences, the firm’s division for investments in companies developing breakthrough therapeutic products and medical technologies, has been actively present in the DACH region for more than 20 years. The firm has been growing steadily with the $575 million closing of its latest BioDiscovery 6 life science fund to which it also attracted German institutional and private investors to join as limited partners. The firm opened an office in Munich in 2021 and plans to strategically expand its outreach in the region with its multiple investment activities, including inviting investors into its diverse funds. Wholly owned by its partners and management team, Andera Partners is headquartered in Paris, with offices in Milan, Munich and Antwerp.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
